Status:
RECRUITING
Hemithoracic Arc Radiotherapy Post Pleural Decortication
Lead Sponsor:
Cairo University
Conditions:
Malignant Pleural Mesothelioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of...
Detailed Description
This study will include malignant Pleural Mesothelioma patients treated by trimodalitiy approach starting with neoadjuvant chemotherapy followed by surgery in the form of Pleural decortication then al...
Eligibility Criteria
Inclusion
- Evidence of metastatic disease.
- Underwent Pleural decortication.
- Able to provide informed consent.
Exclusion
- Poor pulmonary function tests.
- Recurrent or palliative cases.
- Inability to attend full course of Radiotherapy or follow up visits.
Key Trial Info
Start Date :
November 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06910449
Start Date
November 11 2024
End Date
February 1 2027
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
national Cancer Institute Cairo university
Cairo, Fom Elkhalig, Egypt, 11796